Rowan M. Kuiper
Utrecht, UT, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 22 publications
SKY92 Identifies High-Risk Newly Diagnosed Multiple Myeloma With Inferior Progression-Free Survival and Implicates NUF2 as a Candidate Driver.
Journal: European journal of haematology
Published: June 30, 2026
Correlated Residuals in Lagged-Effects Models: What They (Do Not) Represent in the Case of a Continuous-Time Process.
Journal: Multivariate behavioral research
Published: November 10, 2025
Aggregating evidence for a central theory from diverse studies using the generalized order-restricted information criterion.
Journal: Psychological methods
Published: May 29, 2025
Enhancing risk stratification and treatment decision in multiple myeloma with SKY92 gene expression profiling in real-world data.
Journal: British journal of haematology
Published: October 08, 2024
Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 31, 2022
Bridging a diagnostic Kawasaki disease classifier from a microarray platform to a qRT-PCR assay.
Journal: Pediatric research
Published: February 03, 2022
Prognostic gene expression analysis in a retrospective, multinational cohort of 155 multiple myeloma patients treated outside clinical trials.
Journal: International journal of laboratory hematology
Published: April 21, 2021
Analytical Validation of SKY92 for the Identification of High-Risk Multiple Myeloma.
Journal: The Journal of molecular diagnostics : JMD
Published: May 15, 2020
Last Updated: 09/26/2026